These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25018630)

  • 1. Magnetic field enhanced convective diffusion of iron oxide nanoparticles in an osmotically disrupted cell culture model of the blood-brain barrier.
    Sun Z; Worden M; Wroczynskyj Y; Yathindranath V; van Lierop J; Hegmann T; Miller DW
    Int J Nanomedicine; 2014; 9():3013-26. PubMed ID: 25018630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
    Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
    Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cellular uptake and toxicity of aminosilane-coated iron oxide nanoparticles with different charges in central nervous system-relevant cell culture models.
    Sun Z; Yathindranath V; Worden M; Thliveris JA; Chu S; Parkinson FE; Hegmann T; Miller DW
    Int J Nanomedicine; 2013; 8():961-70. PubMed ID: 23494517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternating magnetic field-induced hyperthermia increases iron oxide nanoparticle cell association/uptake and flux in blood-brain barrier models.
    Dan M; Bae Y; Pittman TA; Yokel RA
    Pharm Res; 2015 May; 32(5):1615-25. PubMed ID: 25377069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution of negatively charged iron oxide nanoparticles (IONPs) in mice and enhanced brain delivery using lysophosphatidic acid (LPA).
    Sun Z; Worden M; Thliveris JA; Hombach-Klonisch S; Klonisch T; van Lierop J; Hegmann T; Miller DW
    Nanomedicine; 2016 Oct; 12(7):1775-1784. PubMed ID: 27125435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salinomycin-Loaded Iron Oxide Nanoparticles for Glioblastoma Therapy.
    Norouzi M; Yathindranath V; Thliveris JA; Miller DW
    Nanomaterials (Basel); 2020 Mar; 10(3):. PubMed ID: 32155938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding, transcytosis and biodistribution of anti-PECAM-1 iron oxide nanoparticles for brain-targeted delivery.
    Dan M; Cochran DB; Yokel RA; Dziubla TD
    PLoS One; 2013; 8(11):e81051. PubMed ID: 24278373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bolaamphiphilic vesicles encapsulating iron oxide nanoparticles: new vehicles for magnetically targeted drug delivery.
    Philosof-Mazor L; Dakwar GR; Popov M; Kolusheva S; Shames A; Linder C; Greenberg S; Heldman E; Stepensky D; Jelinek R
    Int J Pharm; 2013 Jun; 450(1-2):241-9. PubMed ID: 23623794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake and transcytosis of functionalized superparamagnetic iron oxide nanoparticles in an in vitro blood brain barrier model.
    Ivask A; Pilkington EH; Blin T; Käkinen A; Vija H; Visnapuu M; Quinn JF; Whittaker MR; Qiao R; Davis TP; Ke PC; Voelcker NH
    Biomater Sci; 2018 Jan; 6(2):314-323. PubMed ID: 29239410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Block copolymer cross-linked nanoassemblies improve particle stability and biocompatibility of superparamagnetic iron oxide nanoparticles.
    Dan M; Scott DF; Hardy PA; Wydra RJ; Hilt JZ; Yokel RA; Bae Y
    Pharm Res; 2013 Feb; 30(2):552-61. PubMed ID: 23080062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity and biodistribution assessment of curcumin-coated iron oxide nanoparticles: Multidose administration.
    Aboushoushah S; Alshammari W; Darwesh R; Elbaily N
    Life Sci; 2021 Jul; 277():119625. PubMed ID: 34015288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison study of ferrofluid and powder iron oxide nanoparticle permeability across the blood-brain barrier.
    Hoff D; Sheikh L; Bhattacharya S; Nayar S; Webster TJ
    Int J Nanomedicine; 2013; 8():703-10. PubMed ID: 23426527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmigration of magnetite nanoparticles across the blood-brain barrier in a rodent model: influence of external and alternating magnetic fields.
    Gupta R; Chauhan A; Kaur T; Kuanr BK; Sharma D
    Nanoscale; 2022 Dec; 14(47):17589-17606. PubMed ID: 36409463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidance of Magnetic Nanocontainers for Treating Alzheimer's Disease Using an Electromagnetic, Targeted Drug-Delivery Actuator.
    Do TD; Ul Amin F; Noh Y; Kim MO; Yoon J
    J Biomed Nanotechnol; 2016 Mar; 12(3):569-74. PubMed ID: 27280254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal iron liberation is responsible for the vulnerability of brain microglial cells to iron oxide nanoparticles: comparison with neurons and astrocytes.
    Petters C; Thiel K; Dringen R
    Nanotoxicology; 2016; 10(3):332-42. PubMed ID: 26287375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of neutral-surface iron oxide nanoparticles on cellular uptake and signaling pathways.
    Kim E; Kim JM; Kim L; Choi SJ; Park IS; Han JY; Chu YC; Choi ES; Na K; Hong SS
    Int J Nanomedicine; 2016; 11():4595-4607. PubMed ID: 27695320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron oxide nanoparticles suppress the production of IL-1beta via the secretory lysosomal pathway in murine microglial cells.
    Wu HY; Chung MC; Wang CC; Huang CH; Liang HJ; Jan TR
    Part Fibre Toxicol; 2013 Sep; 10():46. PubMed ID: 24047432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles.
    Kaluzova M; Bouras A; Machaidze R; Hadjipanayis CG
    Oncotarget; 2015 Apr; 6(11):8788-806. PubMed ID: 25871395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and interfacing of biocompatible iron oxide nanoparticles through the ferroxidase activity of Helicobacter Pylori ferritin.
    Lee IL; Li PS; Yu WL; Shen HH
    Biofabrication; 2012 Dec; 4(4):045001. PubMed ID: 23013844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
    Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.